The Alliance for Biosecurity is a consortium of companies that develop products to respond to national security threats, including bioterrorism pathogens and emerging infectious diseases.

[2] The United States faces risks to national security posed by the danger of bioterrorism or a destabilizing infectious disease pandemic.

The Alliance for Biosecurity is a group of pharmaceutical and biotechnology companies that work to create preventive measures and treatments for severe infectious diseases.

The poll was conducted, in part, to measure support for biosecurity funding because reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) is due by September 30, 2018.

The Alliance advocates for public policies and funding to support the rapid development, production, stockpiling, and distribution of critically needed medical countermeasures.